261 related articles for article (PubMed ID: 31863303)
1. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
Davidov AS; Elkon-Tamir E; Haham A; Shefer G; Weintrob N; Oren A; Lebenthal Y; Mandel D; Eyal O
Eur J Pediatr; 2020 Apr; 179(4):597-602. PubMed ID: 31863303
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with neonatal hyperinsulinemic hypoglycemia, a case-control study.
Rattanasakol T; Kitsommart R
J Pediatr Endocrinol Metab; 2024 Mar; 37(3):243-249. PubMed ID: 38235510
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism.
Hoe FM; Thornton PS; Wanner LA; Steinkrauss L; Simmons RA; Stanley CA
J Pediatr; 2006 Feb; 148(2):207-12. PubMed ID: 16492430
[TBL] [Abstract][Full Text] [Related]
4. Prolonged hyperinsulinemic hypoglycemia in a small for date preterm.
Pezzati M; Barni S; Chiti G; Danesi G; Rubaltelli FF
Minerva Pediatr; 2003 Feb; 55(1):79-82. PubMed ID: 12660630
[TBL] [Abstract][Full Text] [Related]
5. Liver injury may increase the risk of diazoxide toxicity: a case report.
Tas E; Mahmood B; Garibaldi L; Sperling M
Eur J Pediatr; 2015 Mar; 174(3):403-6. PubMed ID: 25618267
[TBL] [Abstract][Full Text] [Related]
6. Development of pulmonary hypertension in an infant treated with diazoxide.
Nebesio TD; Hoover WC; Caldwell RL; Nitu ME; Eugster EA
J Pediatr Endocrinol Metab; 2007 Aug; 20(8):939-44. PubMed ID: 17937066
[TBL] [Abstract][Full Text] [Related]
7. Transient hyperinsulinism in an asphyxiated newborn infant with hypoglycemia.
Clark W; O'Donovan D
Am J Perinatol; 2001 Jun; 18(4):175-8. PubMed ID: 11444360
[TBL] [Abstract][Full Text] [Related]
8. Complications of diazoxide treatment in persistent neonatal hyperinsulinism.
Abu-Osba YK; Manasra KB; Mathew PM
Arch Dis Child; 1989 Oct; 64(10):1496-500. PubMed ID: 2684032
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and management of neonatal onset hyperinsulinemic hypoglycemia: a single neonatal center experience.
Bezirganoglu H; Okur N; Celik K; Tas FF; Ozbek MN
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2272014. PubMed ID: 37860935
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular characterisation of hyperinsulinaemic hypoglycaemia in infants born small-for-gestational age.
Arya VB; Flanagan SE; Kumaran A; Shield JP; Ellard S; Hussain K; Kapoor RR
Arch Dis Child Fetal Neonatal Ed; 2013 Jul; 98(4):F356-8. PubMed ID: 23362136
[TBL] [Abstract][Full Text] [Related]
11. Long-term diazoxide treatment in persistent hyperinsulinemic hypoglycemia of infancy: a patient report.
Darendeliler F; Bundak R; Bas F; Saka N; Günöz H
J Pediatr Endocrinol Metab; 1997; 10(1):79-81. PubMed ID: 9364348
[TBL] [Abstract][Full Text] [Related]
12. Prolonged hyperinsulinism and hypoglycemia. In an asphyxiated, small for gestation infant. Case management and literature review.
Bhowmick SK; Lewandowski C
Clin Pediatr (Phila); 1989 Dec; 28(12):575-8. PubMed ID: 2684473
[TBL] [Abstract][Full Text] [Related]
13. Neonatal hyperinsulinism secondary to maternal intake of high-sugar drinks.
West NJ; Thorpe M
BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689550
[TBL] [Abstract][Full Text] [Related]
14. Palliative treatment of hyperinsulinism with cyproheptadine and diazoxide.
Rotenstein D; Serbin S; Welsh T
Pediatrics; 1992 Aug; 90(2 Pt 1):212-5. PubMed ID: 1379358
[TBL] [Abstract][Full Text] [Related]
15. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism.
Malhotra N; Yau D; Cunjamalay A; Gunasekara B; S A; Gilbert C; Morgan K; Dattani M; Dastamani A
Clin Endocrinol (Oxf); 2024 Feb; 100(2):132-137. PubMed ID: 38059644
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the duration of treatment with diazoxide in infants with prolonged hyperinsulinism (PHI).
Raisingani M; Brar PC
J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1241-1245. PubMed ID: 31465295
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases.
de Lonlay P; Fournet JC; Touati G; Groos MS; Martin D; Sevin C; Delagne V; Mayaud C; Chigot V; Sempoux C; Brusset MC; Laborde K; Bellane-Chantelot C; Vassault A; Rahier J; Junien C; Brunelle F; Nihoul-Fékété C; Saudubray JM; Robert JJ
Eur J Pediatr; 2002 Jan; 161(1):37-48. PubMed ID: 11808879
[TBL] [Abstract][Full Text] [Related]
18. Necrotising enterocolitis in newborns receiving diazoxide.
Prado LA; Castro M; Weisz DE; Jain A; Belik J
Arch Dis Child Fetal Neonatal Ed; 2021 May; 106(3):306-310. PubMed ID: 33172872
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria.
Touati G; Poggi-Travert F; Ogier de Baulny H; Rahier J; Brunelle F; Nihoul-Fekete C; Czernichow P; Saudubray JM
Eur J Pediatr; 1998 Aug; 157(8):628-33. PubMed ID: 9727845
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-sulfamethoxazole induced prolonged hypoglycemia in an infant with MHC class II deficiency: diazoxide as a treatment option.
Gonc EN; Turul T; Yordam N; Ersoy F
J Pediatr Endocrinol Metab; 2003 Dec; 16(9):1307-9. PubMed ID: 14714756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
